Search research articles
Contact Us
Filters
Showing results (21-30 of 97) with videos related to
Page
of 10
Sort By:
British Journal of Clinical Pharmacology
|
July 27, 2018
The association between the NAT2 genetic polymorphisms and risk of DILI during anti-TB treatment: a systematic review and meta-analysis
Min Zhang, Shuqiang Wang, Bob Wilffert, et al.
British Journal of Clinical Pharmacology
|
January 19, 2021
Drug exposure of first-line anti-tuberculosis drugs in China: A prospective pharmacological cohort study
Yazhou Gao, Lina Davies Forsman, Weihua Ren, et al.
Frontiers in Pharmacology
|
June 30, 2020
Saliva for Precision Dosing of Antifungal Drugs: Saliva Population PK Model for Voriconazole Based on a Systematic Review
Hannah Yejin Kim, Anne-Grete Märtson, Erwin Dreesen, et al.
Therapeutic Drug Monitoring
|
October 15, 2021
Therapeutic Drug Monitoring of the Echinocandin Antifungal Agents: Is There a Role in Clinical Practice? A Position Statement of the Anti-Infective Drugs Committee of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology
Hannah Yejin Kim, Sara Baldelli, Anne-Grete Märtson, et al.
Critical Care Medicine
|
May 3, 2021
Predictive Performance of Bayesian Vancomycin Monitoring in the Critically Ill
Sujita W Narayan, Yann Thoma, Philip G Drennan, et al.
Internal Medicine Journal
|
February 22, 2022
Pharmacogenomic testing: perception of clinical utility, enablers and barriers to adoption in Australian hospitals
Angela Pearce, Bronwyn Terrill, Jan-Willem Alffenaar, et al.
Clinical Pharmacokinetics
|
February 28, 2024
Bayesian Vancomycin Model Selection for Therapeutic Drug Monitoring in Neonates
Dua'a Alrahahleh, Yann Thoma, Ruth Van Daele, et al.
Scientific Reports
|
August 28, 2024
Pharmacokinetics of extended-release clarithromycin in patients with Mycobacterium ulcerans infection
Sandor-Adrian Klis, Ymkje Stienstra, Kabiru M Abass, et al.
Frontiers in Pharmacology
|
October 27, 2022
Therapeutic drug monitoring practices of anti-infectives: An Asia-wide cross-sectional survey
Jingjing Hou, Debbie Marriott, Dario Cattaneo, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
March 6, 2025
Beta-lactam combination treatment overcomes rifampicin resistance in Mycobacterium tuberculosis
Diana H Quan, Trixie Wang, Elena Martinez, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 97) with videos related to
Sort By:
Page
of 10
British Journal of Clinical Pharmacology
|
July 27, 2018
The association between the NAT2 genetic polymorphisms and risk of DILI during anti-TB treatment: a systematic review and meta-analysis
Min Zhang, Shuqiang Wang, Bob Wilffert, et al.
British Journal of Clinical Pharmacology
|
January 19, 2021
Drug exposure of first-line anti-tuberculosis drugs in China: A prospective pharmacological cohort study
Yazhou Gao, Lina Davies Forsman, Weihua Ren, et al.
Frontiers in Pharmacology
|
June 30, 2020
Saliva for Precision Dosing of Antifungal Drugs: Saliva Population PK Model for Voriconazole Based on a Systematic Review
Hannah Yejin Kim, Anne-Grete Märtson, Erwin Dreesen, et al.
Therapeutic Drug Monitoring
|
October 15, 2021
Therapeutic Drug Monitoring of the Echinocandin Antifungal Agents: Is There a Role in Clinical Practice? A Position Statement of the Anti-Infective Drugs Committee of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology
Hannah Yejin Kim, Sara Baldelli, Anne-Grete Märtson, et al.
Critical Care Medicine
|
May 3, 2021
Predictive Performance of Bayesian Vancomycin Monitoring in the Critically Ill
Sujita W Narayan, Yann Thoma, Philip G Drennan, et al.
Internal Medicine Journal
|
February 22, 2022
Pharmacogenomic testing: perception of clinical utility, enablers and barriers to adoption in Australian hospitals
Angela Pearce, Bronwyn Terrill, Jan-Willem Alffenaar, et al.
Clinical Pharmacokinetics
|
February 28, 2024
Bayesian Vancomycin Model Selection for Therapeutic Drug Monitoring in Neonates
Dua'a Alrahahleh, Yann Thoma, Ruth Van Daele, et al.
Scientific Reports
|
August 28, 2024
Pharmacokinetics of extended-release clarithromycin in patients with Mycobacterium ulcerans infection
Sandor-Adrian Klis, Ymkje Stienstra, Kabiru M Abass, et al.
Frontiers in Pharmacology
|
October 27, 2022
Therapeutic drug monitoring practices of anti-infectives: An Asia-wide cross-sectional survey
Jingjing Hou, Debbie Marriott, Dario Cattaneo, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
March 6, 2025
Beta-lactam combination treatment overcomes rifampicin resistance in Mycobacterium tuberculosis
Diana H Quan, Trixie Wang, Elena Martinez, et al.
Page
of 10